Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area

scientific article published on 18 September 2017

Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4269/AJTMH.17-0359
P8608Fatcat IDrelease_fjob6zfhvzf7nhl2eef4pdxpxi
P932PMC publication ID5817778
P698PubMed publication ID29016339

P50authorMarcelo Ribeiro-AlvesQ48040879
Josué da Costa Lima-JuniorQ56555271
Cláudio Tadeu Daniel-RibeiroQ60012093
Pierre DruilheQ80328511
P2093author name stringFátima Santos
Daniel Camus
Daiana De Souza Perce-Da-Silva
Dalma Maria Banic
Evelyn Kety Pratt Riccio
Joseli Oliveira-Ferreira
Lilian Rose Pratt-Riccio
Mercia Arruda
P2860cites workMajor Histocompatibility Complex and Malaria: Focus on Plasmodium vivax InfectionQ26767472
Immunoglobulin class switchingQ28285566
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malariaQ31169310
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.Q33305467
The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malariaQ33512926
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparumQ33591313
Isotypic analysis of Plasmodium falciparum-specific antibodies and their relation to protection in MadagascarQ33612549
Malaria in Brazil: an overviewQ33939774
DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malariaQ33957344
High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malariaQ34003525
Antibody recognition of Plasmodium falciparum infected red blood cells by symptomatic and asymptomatic individuals in the Brazilian Amazon.Q34142748
Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area.Q34287358
Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malariaQ34301187
Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparumQ34537136
B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian AmazonQ34726966
Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigensQ34778078
Asymptomatic infection in individuals from the municipality of Barcelos (Brazilian Amazon) is not associated with the anti-Plasmodium falciparum glycosylphosphatidylinositol antibody responseQ34987487
Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adultsQ35093445
Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of KenyaQ35165581
Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malariaQ35386488
THE PASSIVE TRANSFER OF HUMAN MALARIAL IMMUNITY.Q35420711
Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malariaQ35552983
Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican childrenQ35739071
Genetic Resistance to Malaria Is Associated With Greater Enhancement of Immunoglobulin (Ig)M Than IgG Responses to a Broad Array of Plasmodium falciparum AntigensQ36042702
Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich proQ36227049
Humoral responses to plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa.Q36421572
Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, PeruQ36531268
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malariaQ36594057
Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in EthiopiaQ36741193
High prevalence of asymptomatic malaria in gold mining areas in BrazilQ48004091
Immunologic responses to soluble exoantigens of Plasmodium falciparum in Gabonese children exposed to continuous intense infectionQ48005617
Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.Q48012112
Evaluation of host humoral antibody production against Plasmodium falciparum recombinant circumsporozoite antigen in Nigerian children.Q48024856
Detection and identification of the four malaria parasite species infecting humans by PCR amplification.Q48030204
Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodiesQ48071892
Automated multiple peptide synthesisQ52411545
HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantationQ67522337
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)Q71608623
Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in IndiaQ36800846
Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian AmazonQ36835626
Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunityQ36943252
Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan childrenQ37023939
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illnessQ37099503
Immunity to malaria: more questions than answersQ37194482
Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of BrazilQ37363110
Human leukocyte antigen class II alleles influence levels of antibodies to the plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1Q37426223
Antibodies to the N-terminal block 2 of plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malariaQ37582802
Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivaxQ37682153
Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in MozambiqueQ37702603
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malariaQ39247931
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal KenyaQ39362550
Asymptomatic infection with Plasmodium falciparum and Plasmodium vivax in the Brazilian Amazon Basin: to treat or not to treat?Q39504456
Urban malaria in the Brazilian Western Amazon Region I: high prevalence of asymptomatic carriers in an urban riverside district is associated with a high level of clinical malariaQ39504463
Dynamics of the antibody response to Plasmodium falciparum infection in African childrenQ39589730
A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.Q40640896
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New GuineaQ40694087
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.Q40734085
Pattern of antibodies to the Duffy binding like domain of Plasmodium falciparum antigen Pf332 in Senegalese individualsQ41392065
Is Fc gamma receptor IIA (FcγRIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso?Q41635798
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stagesQ41835030
Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytesQ42938913
The epidemiology of malaria in Rondonia (Western Amazon region, Brazil): study of a riverine populationQ44140387
Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypesQ44144189
Differential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bitesQ44164631
Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growthQ44575916
Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa).Q44710649
Lymphocyte proliferation and antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with seasonal variation in malaria transmission.Q45068855
The presence of the HLA class II allele DPB1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigenQ45157941
Influence of HLA-DRB1 alleles on antibody responses to PfCP-2.9-immunized and naturally infected individuals.Q46086616
Differential antibody responses to Plasmodium falciparum invasion ligand proteins in individuals living in malaria-endemic areas in Brazil and Cameroon.Q46298357
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.Q46334562
Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.Q46339260
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.Q47830190
Immune response and lack of immune response to Plasmodium falciparum P126 antigen and its amino-terminal repeat in malaria-infected humansQ47833716
Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patientsQ47836433
Interleukin-21 is associated with IgG1 and IgG3 antibodies to erythrocyte-binding antigen-175 peptide 4 of Plasmodium falciparum in Gabonese children with acute falciparum malariaQ47861367
Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparumQ47872379
Natural human IgG subclass antibodies to Plasmodium falciparum blood stage antigens and their relation to malaria resistance in an endemic area of Thailand.Q47889819
Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2.Q47900627
Human leukocyte antigen class II control of the immune response to p126-derived amino terminal peptide from Plasmodium falciparumQ47911320
High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populationsQ47911926
Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemiaQ47954510
HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malariaQ47990902
Influence of HLA-DRB-1 alleles on the production of antibody against CSP, MSP-1, AMA-1, and DBP in Brazilian individuals naturally infected with Plasmodium vivaxQ47995600
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectPlasmodium falciparumQ311383
P304page(s)1581-1592
P577publication date2017-09-18
P1433published inAmerican Journal of Tropical Medicine and HygieneQ15766943
P1476titleSynthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area
P478volume97

Reverse relations

Q90235828Evaluation of Plasmodium falciparum MSP10 and its development as a serological tool for the Peruvian Amazon regioncites workP2860

Search more.